During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...
Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from ...
Oslo-based Tribune Therapeutics has raised $40 million to advance its way of inhibiting the formation of scar tissue in disease. The cash from investors including LifeArc Ventures, Novo Holdings, and ...
Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung ...
5don MSN
“Importantly, both fatty15 and rapamycin demonstrated anti-inflammatory, antioxidant, antifibrotic, anticancer and antimicrobial activities, all of which are expected to help extend our healthspan and ...
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...
“Importantly, both fatty15 and rapamycin demonstrated anti-inflammatory, antioxidant, antifibrotic, anticancer and antimicrobial activities, all of which are expected to help extend our ...
Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease----Data Presented at the 2025 Muscular ...
These stromal cells secrete bioactive elements (eg, growth factors, exosomes) that have been shown to exert immunomodulatory, antifibrotic, anti-inflammatory and pro-angiogenic effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback